| ||||||||||||||
|
|
|||||||||||||
From the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts.
Abstract
BACKGROUND: Intrathecal morphine for cesarean delivery provides excellent postoperative analgesia but is associated with significant nausea and vomiting.
METHODS: We compared the antiemetic efficacy of transdermal scopolamine, IV ondansetron, and placebo during the first 24 h postoperatively. Two-hundred forty women undergoing cesarean delivery under spinal anesthesia were randomly allocated, in a double-blind study design, to receive transdermal scopolamine 1.5 mg, ondansetron 4 mg, or placebo at the time of cord clamping.
RESULTS: Our study showed that the overall rates for all emesis were 59.3% in the placebo group and were reduced to 40% in the scopolamine group and 41.8% in the ondansetron group. The greatest reduction in emesis in the scopolamine group when compared with placebo was in the 6–24 h time period.
CONCLUSION: Scopolamine is an effective medication for prophylactic use in parturients receiving intrathecal morphine while undergoing cesarean delivery. Its use, however, was associated with a higher incidence of side effects such as dry mouth and blurry vision.
This article has been cited by other articles:
![]() |
S. Apiliogullari and A. Duman Smoking and Nalbuphine May Reduce Postoperative Emesis Anesth. Analg., July 1, 2008; 107(1): 344 - 344. [Full Text] [PDF] |
||||
![]() |
M. Harnett and S. Segal Smoking and Nalbuphine May Reduce Postoperative Emesis Anesth. Analg., July 1, 2008; 107(1): 344 - 344. [Full Text] [PDF] |
||||
|